Analytical Data
-
基因名
OFX
- Application
-
别名
OFX；Baf190a；Brg1；Snf2b；Transcription activator BRG1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P51532
-
表达区间
700-1246aa
-
氨基酸序列
EVDARHIIENAKQDVDDEYGVSQALARGLQSYYAVAHAVTERVDKQSALMVNGVLKQYQIKGLEWLVSLYNNNLNGILADEMGLGKTIQTIALITYLMEHKRINGPFLIIVPLSTLSNWAYEFDKWAPSVVKVSYKGSPAARRAFVPQLRSGKFNVLLTTYEYIIKDKHILAKIRWKYMIVDEGHRMKNHHCKLTQVLNTHYVAPRRLLLTGTPLQNKLPELWALLNFLLPTIFKSCSTFEQWFNAPFAMTGEKVDLNEEETILIIRRLHKVLRPFLLRRLKKEVEAQLPEKVEYVIKCDMSALQRVLYRHMQAKGVLLTDGSEKDKKGKGGTKTLMNTIMQLRKICNHPYMFQHIEESFSEHLGFTGGIVQGLDLYRASGKFELLDRILPKLRATNHKVLLFCQMTSLMTIMEDYFAYRGFKYLRLDGTTKAEDRGMLLKTFNEPGSEYFIFLLSTRAGGLGLNLQSADTVIIFDSDWNPHQDLQAQDRAHRIGQQNEVRVLRLCTVNSVEEKILAAAKYKLNVDQKVIQAGMFDQKSSSHERRAF
-
分子量
64.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of OFX (Oxidative Stress Factor X) recombinant proteins has gained significant attention in recent years due to their potential implications in various biomedical fields, particularly in understanding oxidative stress-related diseases. Oxidative stress, resulting from an imbalance between reactive oxygen species production and antioxidant defenses, is implicated in numerous pathologies, including cancer, neurodegenerative disorders, and cardiovascular diseases. OFX has been identified as a pivotal player in cellular responses to oxidative stress, influencing cell survival, apoptosis, and inflammation. By generating recombinant OFX proteins, researchers aim to elucidate the molecular mechanisms underlying OFX's role in oxidative stress management and to assess its potential as a therapeutic target. The production of these proteins facilitates high-throughput screening of potential drug candidates and enhances our understanding of OFX's interactions with various cellular pathways. Furthermore, studying OFX recombinant proteins could lead to the identification of biomarkers for early diagnosis of oxidative stress-related conditions, ultimately paving the way for novel therapeutic strategies to mitigate the adverse effects of oxidative damage in human health. As the field of oxidative stress research continues to evolve, the insights gained from the investigation of OFX recombinant proteins hold promise for advancing our knowledge and developing innovative approaches to combat diseases associated with oxidative stress.
